Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Litton Mark James Create: Alert

All | News | Filings
Date FiledTypeDescription
01/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/31/2022 4 Litton Mark James (CEO) has filed a Form 4 on Athira Pharma, Inc.
Txns: Granted 885 shares @ $12.51, valued at $11.1k
Granted 400,000 options to buy @ $9.91, valued at $4M
08/19/2021 4 Litton Mark James (COO) has filed a Form 4 on Athira Pharma, Inc.
Txns: Granted 867 shares @ $14.45, valued at $12.5k
Exercised 50,440 options to buy @ $1.35, valued at $68.1k
02/22/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/22/2020 4 Litton Mark James (COO) has filed a Form 4 on Athira Pharma, Inc.
Txns: Converted 13,126 shares @ $0
Converted 6,563 shares @ $0
Converted 13,126 preferred shares @ $0
Converted 6,563 preferred shares @ $0
02/08/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/08/2018 4 Litton Mark James (See Remarks) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns: Granted 150,000 options to buy @ $6.81, valued at $1M
06/05/2018 4 Litton Mark James (Chief Business Officer) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC
Txns: Sold 18,253 shares @ $17.7409, valued at $323.8k
Sold 4,474 shares @ $18.2358, valued at $81.6k
Exercised 22,727 options to buy @ $0.99, valued at $22.5k
02/21/2018 4 Litton Mark James (Chief Business Officer) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC
Txns: Granted 75,000 options to buy @ $13.55, valued at $1M
11/15/2017 4 Litton Mark James (Chief Business Officer) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC
Txns: Sold 16,519 shares @ $10.8049, valued at $178.5k
Exercised 16,519 options to buy @ $1.65, valued at $27.3k
10/18/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/31/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/20/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/09/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
10/19/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
07/14/2016 4 Litton Mark James (Chief Business Officer) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC
Txns: Exercised 25,000 options to buy @ $0.385, valued at $9.6k
06/15/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
06/01/2016 4 Litton Mark James (Chief Business Officer) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC
Txns: Sold 5,280 shares @ $30.0555, valued at $158.7k
Sold 19,720 shares @ $30.049, valued at $592.6k
Exercised 5,280 options to buy @ $0.385, valued at $2k
Exercised 19,720 options to buy @ $0.385, valued at $7.6k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy